Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Pediatr Infect Dis J ; 18(8): 714-21, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10462342

ABSTRACT

BACKGROUND: Aboriginal children in central Australia have attack rates for acute lower respiratory tract infection (ALRI) that are similar to those in developing countries. Although mortality rates are much lower than in developing countries, morbidity is high and ALRI is still the leading cause of hospitalization. However, there are no data on the etiology of ALRI in this population. METHODS: We prospectively studied 322 cases of ALRI in 280 Aboriginal children admitted to the hospital. Blood, urine and nasopharyngeal aspirate samples were examined for evidence of bacterial, viral and chlamydial infection. RESULTS: The combination of blood culture, viral studies and chlamydial serology provided at least 1 etiologic agent in 170 of 322 (52.5%) cases. Assays for pneumolysin immune complex and pneumolysin antibody increased etiologic diagnosis to 219 (68.0%). Blood cultures were positive in 6% but pneumolysin immune complex and pneumolysin antibody studies were positive in one-third of cases. Evidence of viral infection was present in 155 (48%) of cases compared with 12% in controls (P < 001). There were only 7 possible cases and 2 definite cases of Chlamydia trachomatis and 3 cases of Chlamydia pneumoniae. Coinfection was common in these children. CONCLUSION: These findings have implications for both standard treatment protocols and vaccine strategies. The high rate of coinfection may make it difficult to develop simple clinical predictors of bacterial infection. In the setting of a developed country with efficient patient evacuation services, management algorithms that focus on disease severity and need for hospital referral will be most useful to health staff in remote communities. Pneumococcal conjugate vaccines will be required to reduce the high attack rate of pneumococcal disease.


Subject(s)
Bacterial Infections/ethnology , Native Hawaiian or Other Pacific Islander , Respiratory Tract Infections/microbiology , Virus Diseases/ethnology , Australia/epidemiology , Bacteria/isolation & purification , Bacterial Infections/microbiology , Bacterial Proteins , Child, Preschool , Chlamydia/isolation & purification , Chlamydia Infections/ethnology , Chlamydia Infections/microbiology , Female , Humans , Infant , Infant, Newborn , Male , Prospective Studies , Respiratory Tract Infections/ethnology , Respiratory Tract Infections/virology , Specimen Handling/methods , Streptolysins/analysis , Virus Diseases/virology , Viruses/isolation & purification
2.
Pediatr Infect Dis J ; 13(11): 983-9, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7845752

ABSTRACT

Otitis media (OM) develops in the first months of life and persists throughout childhood in many rural Aboriginal children. We have followed Aboriginal and non-Aboriginal infants from birth to determine the relationship of the early onset of OM to nasopharyngeal colonization with respiratory pathogens. Aboriginal infants were colonized with multiple species of respiratory bacteria (Moraxella catarrhalis, Haemophilus influenzae, Streptococcus pneumoniae) at a rate of 5% per day and the timing of colonization predicted the onset of persistent OM in individual Aboriginal infants. Non-Aboriginal infants became colonized by M. catarrhalis alone at the slower rate of 1% per day and experienced transient episodes of OM in the absence of colonization. We attribute early bacterial colonization in most Aboriginal infants to high rates of cross-infection due to overcrowding, poor hygiene and high rates of bacterial carriage. Early age of infection and the multiplicity of bacterial types may contribute to prolonged carriage and to eustachian tube damage leading to persistent OM. Thus Aboriginal infants are "otitis-prone" and might qualify for prophylactic antibiotics.


Subject(s)
Nasopharynx/microbiology , Native Hawaiian or Other Pacific Islander , Otitis Media/diagnosis , Age Factors , Age of Onset , Australia , Haemophilus influenzae/isolation & purification , Humans , Infant , Infant, Newborn , Moraxella/isolation & purification , Prognosis , Recurrence , Rural Population , Streptococcus pneumoniae/isolation & purification
3.
Article in English | MEDLINE | ID: mdl-7825002

ABSTRACT

When nasopharyngeal secretions from 171 Australian Aboriginal children hospitalized with acute lower respiratory tract infections (ALRI) were cultured selectively for Streptococcus pneumoniae and Haemophilus influenzae, 136 (79.5%) and 151 (88.3%) children yielded 166 and 254 isolates of S. pneumoniae and H. influenzae, respectively. In colonized subjects multiple populations of S. pneumoniae (20% of carriage-positive patients) and H. influenzae (55%) were common. Pneumococci belonging to 27 types or groups were identified. H. influenzae serotype b colonized 16.4% of all children studied. More than one half of 152 children tested were excreting antibiotics at the time of admission to hospital. Significantly fewer children with serum antibiotic residues were colonized with S. pneumoniae than were antibiotic free children. Antibiotic usage had no measurable impact on the isolation rate of H. influenzae.


Subject(s)
Carrier State/ethnology , Carrier State/microbiology , Haemophilus Infections/ethnology , Haemophilus Infections/microbiology , Haemophilus influenzae , Hospitalization , Infection Control , Nasopharynx/microbiology , Native Hawaiian or Other Pacific Islander , Pneumococcal Infections/ethnology , Pneumococcal Infections/microbiology , Respiratory Tract Infections/ethnology , Respiratory Tract Infections/microbiology , Acute Disease , Anti-Bacterial Agents/blood , Anti-Bacterial Agents/therapeutic use , Carrier State/blood , Carrier State/drug therapy , Child , Child, Preschool , Drug Monitoring , Drug Residues , Drug Utilization , Female , Haemophilus Infections/blood , Haemophilus Infections/drug therapy , Haemophilus influenzae/classification , Humans , Infant , Infant, Newborn , Male , Pneumococcal Infections/blood , Pneumococcal Infections/drug therapy , Racial Groups , Respiratory Tract Infections/blood , Respiratory Tract Infections/drug therapy , Serotyping , Streptococcus pneumoniae/classification
4.
Aust Fam Physician ; 22(10): 1763-8, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8280000

ABSTRACT

The streptococci remain important human pathogens despite it being nearly 60 years since sulphonamides were introduced. Rheumatic fever and post glomerulonephritis are common diseases in the Aboriginal community, and a new invasive disease, toxic shock-like syndrome, is also caused by Group A Streptococcus. Group B, first described over 50 years ago in obstetric wards remains the primary neonatal pathogen despite attempts to eliminate this organism from the genital tract of the carrier mother. A major concern in paediatrics is the relatively poor response to the current pneumococcal vaccines. Australian researchers are playing a major role in developing a new vaccine with high antigenicity against all of the 100 odd serotypes of S pneumoniae. The oral streptococci are now recognised as important opportunistic pathogens and the pathogenesis is well defined. Disturbing reports from different geographical regions alert us to the antibiotic resistance in some of the streptococci once thought of as sensitive bacteria, for example, Group A has shown resistance to erythromycin, the pneumococcus to penicillin and beta-lactam antibiotics and the aminoglycosides have been ineffective against the enterococci due to plasmid-borne genes.


Subject(s)
Streptococcal Infections , Streptococcus , Bacterial Vaccines/pharmacology , Bacterial Vaccines/therapeutic use , Child , Drug Resistance, Microbial , Enterococcus faecalis/drug effects , Enterococcus faecalis/isolation & purification , Humans , Mouth Diseases/microbiology , Pneumococcal Infections/drug therapy , Pneumococcal Infections/microbiology , Pneumococcal Vaccines , Streptococcal Infections/classification , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Streptococcus/classification , Streptococcus/drug effects , Streptococcus/isolation & purification , Streptococcus agalactiae/drug effects , Streptococcus agalactiae/isolation & purification , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/isolation & purification , Streptococcus pyogenes/drug effects , Streptococcus pyogenes/isolation & purification
5.
Med J Aust ; 158(5): 340-2, 1993 Mar 01.
Article in English | MEDLINE | ID: mdl-8474377

ABSTRACT

An outbreak of serotype 1 Streptococcus pneumoniae infection involving both adults and children occurred in central Australia during the winter months of 1991. Eighteen patients, mainly Aboriginal men, presented with culture-positive serotype 1 bacteraemic pneumonia. In this group, 11 of 12 adults for whom medical records were available were alcohol dependent. Thirteen children who were separately studied were hospitalised with acute lower respiratory tract infection: none had bacteraemia but all had upper airway colonisation by type 1 pneumococci. Antibiotics taken by 8 of the 13 children before admission to hospital may have compromised the isolation of type 1 pneumococci from blood cultures. Since the availability of antibiotics, epidemic pneumococcal infection is infrequent and has not been reported in Australia. In three outbreaks of type 1 disease recorded elsewhere crowding and alcoholism were identified as contributory factors. In the 16 month period before this outbreak none of 162 strains of pneumococci isolated from blood (32 strains) and nasopharyngeal secretions (130 strains) from Aborigines with acute lower respiratory tract infection and meningitis in the Alice Springs region were serotype 1 organisms.


Subject(s)
Disease Outbreaks , Native Hawaiian or Other Pacific Islander , Pneumococcal Infections/epidemiology , Adult , Aged , Australia/epidemiology , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Pneumococcal Infections/microbiology , Serotyping , Streptococcus pneumoniae/classification
6.
J Med Microbiol ; 37(3): 176-9, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1518033

ABSTRACT

Single specimens of diarrhoeal stool from 676 patients, mostly aboriginals aged less than 5 years, admitted to Alice Springs Hospital, central Australia, for diarrhoea between Sept. 1988 and Feb. 1989, were examined for Campylobacter spp. by culture on a blood-free medium with selective supplement (BFM; Oxoid) and blood agar overlaid with a membrane filter (FM). Campylobacter spp. were isolated on either BFM or FM or both from 225 patients. Campylobacter spp. were isolated on BFM alone from 75 patients and on FM alone from 213 patients (p less than 0.001; chi 2 test). Most campylobacters isolated on BFM were C. jejuni. All C. jejuni subsp. doylei, all "C. upsaliensis" except one, all C. laridis, C. fetus subsp. fetus and several uncharacterised Campylobacter isolates were isolated on FM only. C. jejuni was isolated on BFM but not FM from several patients, and vice versa. Serotyping of C. jejuni and C. coli isolated from both media showed the serotypes recovered from the two media to be different in some patients. In some patients concurrent infection with several species or serotypes (up to five) of Campylobacter, or both, was shown for the first time by the use of FM. We conclude that the use in combination of a selective medium and a non-selective medium with a filtration technique are better than either medium alone for the isolation of Campylobacter spp.


Subject(s)
Campylobacter Infections/microbiology , Campylobacter/isolation & purification , Diarrhea/microbiology , Feces/microbiology , Acute Disease , Campylobacter/classification , Campylobacter Infections/epidemiology , Child, Preschool , Culture Media, Serum-Free , Diarrhea/epidemiology , Diarrhea, Infantile/microbiology , Filtration , Humans , Infant , Native Hawaiian or Other Pacific Islander , Northern Territory/epidemiology , Serotyping
7.
Clin Infect Dis ; 15(1): 163-9, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1617057

ABSTRACT

Pseudomonas pseudomallei, which causes melioidosis, is most commonly associated with pulmonary infection. We describe seven patients who developed a neurological syndrome as the predominant manifestation of melioidosis: this syndrome was characterized by peripheral motor weakness (mimicking Guillain-Barré syndrome), brain-stem encephalitis, aseptic meningitis, and respiratory failure. Neurological melioidosis occurred in the absence of demonstrable foci of infection in the central nervous system (CNS) in five of six patients whose cerebrospinal fluid was available for culture. Computed tomography and magnetic resonance imaging of the brain and spinal cord of these patients were not suggestive of pyogenic infection, although the latter procedure detected brain-stem encephalitis. Autopsy findings in one case confirmed brain-stem encephalitis without evidence of direct bacterial infection. The clinical presentation of neurological melioidosis includes features of an exotoxin-induced neurological syndrome, with profound neurological disease occurring in the absence of apparent direct infection of the CNS. This syndrome appears to be a newly recognized clinical presentation of melioidosis.


Subject(s)
Melioidosis/diagnosis , Melioidosis/epidemiology , Nervous System Diseases/microbiology , Adult , Australia/epidemiology , Female , Humans , Male , Middle Aged
8.
J Clin Microbiol ; 30(1): 207-10, 1992 Jan.
Article in English | MEDLINE | ID: mdl-1370848

ABSTRACT

Campylobacter jejuni and/or Campylobacter coli was cultured from 218 of 1,078 patients of all age groups admitted to Alice Springs Hospital, Alice Springs, central Australia, between July 1988 and June 1989 for treatment of diarrhea. One hundred sixty-six Campylobacter colonies from 127 patients were subjected to O serotyping by using the Penner typing scheme. All except 29 colonies could be serotyped. A total of 46 serotypes were identified, and the predominant serotypes were O:8, 17, O:22, O:1,44, and O:19. A large proportion of colonies reacted with more than one antiserum, and nine serotypes had antigenic compositions not observed previously. Several patients had multiple infections with more than one serotype, and some patients were shown for the first time to be infected with up to three different serotypes. Repeated reinfections with different serotypes were seen in some patients. In some patients, provided it was not due to reinfection with the same serotype, long-term excretion of the same serotype was seen, and for the first time, one patient showed evidence of excretion of the same serotype for up to 73 days.


Subject(s)
Campylobacter Infections/microbiology , Campylobacter coli/classification , Campylobacter jejuni/classification , Diarrhea/microbiology , Antigens, Bacterial/analysis , Campylobacter Infections/epidemiology , Campylobacter coli/immunology , Campylobacter jejuni/immunology , Diarrhea/epidemiology , Feces/microbiology , Hospitalization , Humans , Northern Territory/epidemiology , O Antigens , Serotyping
9.
Med J Aust ; 150(9): 483-5, 1989 May 01.
Article in English | MEDLINE | ID: mdl-2725404

ABSTRACT

A total of 2124 women who attended the Richmond Family Planning Association Clinic in Melbourne consecutively were screened for the presence or absence of Chlamydia trachomatis. One hundred and three women were found to have Chl. trachomatis infection of the cervix and were invited to participate in a clinical trial of minocycline and doxycycline for the treatment of chlamydial infection. A 10-day course of either drug resulted in a negative result of a chlamydial culture for all patients at the follow-up assessment, which occurred between 11 days to 12 weeks after the therapy. Minocycline and doxycycline showed equal effectiveness in the eradication of mycoplasmas in over 80% of the treated patients. Minocycline appeared to have a slight advantage with respect to the resolution of the gynaecological symptoms that were associated with the chlamydial infection. The number of adverse events that were recorded during the trial was similar for both treatment regimens. Gynaecological symptoms were associated with chlamydial infection in approximately 50% of the women in the study. The lack of association between chlamydial infection and gynaecological symptoms has led to the instigation of routine testing for the presence of Chlamydia spp. in young women who have more than one sexual partner.


Subject(s)
Chlamydia Infections/drug therapy , Doxycycline/therapeutic use , Minocycline/therapeutic use , Tetracyclines/therapeutic use , Uterine Cervical Diseases/drug therapy , Adult , Age Factors , Chlamydia trachomatis , Female , Humans , Leukorrhea/drug therapy , Prospective Studies , Random Allocation , Sexual Partners , Uterine Cervicitis/drug therapy
10.
Aust N Z J Obstet Gynaecol ; 28(3): 216-20, 1988 Aug.
Article in English | MEDLINE | ID: mdl-3148302

ABSTRACT

One thousand consecutive women who attended the Richmond Family Planning Association Clinic and who were to undergo a vaginal examination were asked to participate in a large prospective microbiological study. Participants were questioned about their sexual activity during the previous 12 months and any apparent signs of sexually transmitted disease. On examination the cervix was inspected for evidence of inflammation, ectopy or discharge and cervical swabs were taken microbiological assessment. Chlamydia trachomatis was isolated in 5.1% of women tested while Ureaplasma urealyticum and Mycoplasma hominis were found in 48.8% and 16.4% of women respectively. Significant associations were found between the number of sexual partners during the previous 12 months and the incidence of all 3 organisms. The carriage rate of the genital mycoplasmas was significantly affected by the type of contraception. In addition the association between the presence of the genital mycoplasmas and pelvic and cervical abnormalities was determined.


Subject(s)
Mass Screening , Uterine Cervical Diseases/prevention & control , Animals , Australia , Candida albicans/isolation & purification , Chlamydia trachomatis/isolation & purification , Female , Gardnerella vaginalis/isolation & purification , Humans , Mycoplasma Infections/drug therapy , Mycoplasma Infections/epidemiology , Mycoplasma Infections/microbiology , Mycoplasma Infections/prevention & control , Neisseria gonorrhoeae/isolation & purification , Sexually Transmitted Diseases, Bacterial , Sexually Transmitted Diseases, Viral , Trichomonas vaginalis/isolation & purification , Ureaplasma/isolation & purification , Uterine Cervical Diseases/drug therapy , Uterine Cervical Diseases/epidemiology , Uterine Cervical Diseases/microbiology , Vaginal Smears
11.
Med J Aust ; 147(11-12): 550-2, 1987.
Article in English | MEDLINE | ID: mdl-3501060

ABSTRACT

A prospective study was carried out to determine the prevalence of Chlamydia trachomatis among 1000 sexually-active women at the Family Planning Association Clinic in Melbourne. This organism was isolated from the cervices of 5.1% of screened women. The women were surveyed about their sexual and gynaecological history, and symptoms of discharge or pain. It was found that women who gave positive results for the presence of Chlamydia were younger, and had commenced intercourse at an earlier age. Risk factors of multiple sexual partners, cervical ectopy and symptoms of urethritis were identified. We recommend that women who have more than one sexual partner should ask their partners to use condoms or, failing this, undergo annual screening for Chlamydia by immunofluorescent staining.


PIP: A prospective study was conducted over the December 11, 1985-May 29, 1986, period to determine the prevalence of "Chlamydia trachomatis" among 1000 sexually-active women at Melbourne's (Australia) Family Planning Association Clinic. An epidemiological and clinical history was recorded on a code sheet for study participants. Patients' ages, weights, coitarches, numbers of sexual partners during the last 12 months, and lengths of association with their present partners were recorded along with current contraceptive usage and the results of the last Papanicolaou smear-test. Patients also were asked about the presence of any symptoms of sexually-transmitted disease (STD). The appearance of the cervix was ascertained on speculum examination. Cervical specimens were taken from all women for microbiological assessment. 995 patients completed the patient record form. In 994 of these women, satisfactory swabs were taken for microbiological examination. The patients ranged in age from 15-50 years with a mean age of 25.4. The age at 1st intercourse (coitarche) ranged from 12-30 years and the number of sexual partners during the last 12 months from none to more than 10 partners. 573 (57.6%) women were using oral contraceptives (OCs), 141 (14.2%) no contraception, 101 (10.2%) an IUD, 118 (11.9%) a barrier method, and the remainder a progestagen-only pill, an injectable contraceptive agent, sterilization, or natural contraceptive methods. The previous cervical cytology was available for 775 (77.9%) women; 625 (80.6%) of these showed no abnormal cells. Of the 150 smear-tests that showed some abnormality, only 10 tests demonstrated dysplastic lesions. The rest were indicative of infection or a benign abnormality. Of the 994 cervical swabs, 51 (5.1%) swabs grew Chlamydia trachomatis. 42 swabs gave positive results of both immunofluorescence staining and culture; 9 swabs gave positive results of culture alone. An association between other factors and the presence or absence of Chlamydia was determined. When the ages of patients were compared, patients whose swabs gave positive results for Chlamydia were significantly younger than those whose swabs gave negative results. The women whose swabs gave positive results for Chlamydia began intercourse at a significantly younger age. The prevalence of Chlamydia trachomatis in a young sexually-active population was 5.1%; the group with multiple partner was identified as being at high risk (9.3% positive results). In trying to identify women with an increased risk of carrying Chlamydia, 5 factors appeared relevant: younger age at coitarche; a younger age; more than 1 sexual partner during the previous 12 months; symptoms of urethritis; and the presence of cervical ectopy.


Subject(s)
Chlamydia Infections/epidemiology , Sexually Transmitted Diseases/transmission , Adult , Chlamydia Infections/transmission , Chlamydia trachomatis/isolation & purification , Contraception Behavior , Cross-Sectional Studies , Female , Humans , Middle Aged , Prospective Studies , Sexual Behavior , Victoria
12.
J Med Microbiol ; 21(4): 331-6, 1986 Jun.
Article in English | MEDLINE | ID: mdl-3088280

ABSTRACT

The locus responsible for mucoid colony morphology in five independent clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients have been transferred by means of pM060-mediated conjugation to the genetically characterised strain P. aeruginosa PAO. Genetic mapping has shown that in all five strains the locus is on the chromosome between 89' and 94', although it is not possible to say that the same locus is involved in each case. The way is now open for a more detailed genetic analysis of the loci responsible for mucoid colony morphology.


Subject(s)
Chromosomes, Bacterial , Conjugation, Genetic , Cystic Fibrosis/microbiology , Pseudomonas aeruginosa/genetics , Chromosome Mapping , Humans , Mutation , Phenotype , Pseudomonas aeruginosa/cytology , Pseudomonas aeruginosa/isolation & purification
13.
Med J Aust ; 1(11): 455-9, 1982 May 29.
Article in English | MEDLINE | ID: mdl-7099075

ABSTRACT

Methicillin-resistant Staphylococcus aureus has become an important nosocomial pathogen in the four special-care nurseries in Melbourne during the past two years. Once introduced into a nursery, it can spread rapidly unless specific precautions are taken to prevent it. It has been responsible for a number of serious infections in susceptible infants who have required treatment with the potentially toxic antibiotic agent, vancomycin. Because of the interdependence of the four special-care nurseries, a coordinated approach to infection control is required to minimise the spread of the organism and the associated increased morbidity.


Subject(s)
Cross Infection/microbiology , Infant, Newborn, Diseases/microbiology , Intensive Care Units, Neonatal , Methicillin/pharmacology , Penicillin Resistance , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Australia , Bacteriophage Typing , Communicable Disease Control , Hospitals, Pediatric , Hospitals, Teaching , Humans , Infant, Newborn , Infant, Premature, Diseases/microbiology , Microbial Sensitivity Tests
14.
Med J Aust ; 1(11): 451-4, 1982 May 29.
Article in English | MEDLINE | ID: mdl-7099074

ABSTRACT

During 1979, the Victorian Health Commission received reports of a rising proportion of methicillin-resistant Staphylococcus aureus (MRSA) isolates from an increasing number of institutions. At least 31 metropolitan hospitals were involved, and six of these reported MRSA totaling between 20% and 40% of all Staph. aureus isolates. Since that time, the problem has continued. In some university teaching hospitals, strains of MRSA now cause from 200 to 300 new cases of hospital-acquired infection each year. Sepsis occurs mainly in patients who underwent surgery, premature neonates and in the immunocompromised or debilitated patients. The organism involved is multiresistant. Recent isolates show increasing resistance, particularly against gentamicin, chloramphenicol and, more lately, fusidic acid and rifampicin. Only vancomycin can be relied upon for empirical treatment. There is concern that increasing use of vancomycin will select vancomycin-resistant strains of MRSA, so that, in the near future, there may no longer be any effective antibiotic therapy against hospital staphylococci.


Subject(s)
Cross Infection/microbiology , Disease Outbreaks/epidemiology , Methicillin/pharmacology , Penicillin Resistance , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Australia , Cross Infection/drug therapy , Hospitals, Municipal , Hospitals, Teaching , Hospitals, University , Humans , Infant, Newborn , Staphylococcal Infections/drug therapy , Vancomycin/therapeutic use
15.
Med J Aust ; 2(6): 283-6,287, 1981 Sep 19.
Article in English | MEDLINE | ID: mdl-6795429

ABSTRACT

Strains of Pseudomonas aeruginosa resistant to gentamicin, tobramycin, streptomycin, and sulphonamide have been isolated from patients at two Sydney hospitals. The multiple resistance of all these strains was due to a transmissible plasmid. The significance of the identification of this plasmid, in this variety of strains and at two hospitals, for the treatment of Ps. aeruginosa infections is discussed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Gentamicins/pharmacology , Pseudomonas aeruginosa/drug effects , R Factors , Tobramycin/pharmacology , Australia , Cross Infection/microbiology , Hospitals , Humans , Pseudomonas Infections/drug therapy , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa/genetics , Streptomycin/pharmacology , Sulfonamides/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL